Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: A role for CXCR2

Journal of Leukocyte Biology

Volumn 76, Issue 2, 2004, Pages 441-450

  Traves, Suzanne L ^a   Smith, Susan J ^a   Barnes, Peter J ^a   Donnelly, Louise E ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Chemotaxis; GRO ; Macrophages; NAP 2

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN; NEUTROPHIL ACTIVATING PEPTIDE 2; UNCLASSIFIED DRUG;

ADULT; AGED; CELL INFILTRATION; CHEMOTAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GROWTH RELATED ONCOGENE ALPHA; HOST RESISTANCE; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MONOCYTE; ONCOGENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

ADULT; AGED; CELL MOVEMENT; CHEMOKINES, CC; CHEMOKINES, CXC; CHEMOTAXIS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MONOCYTES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, INTERLEUKIN-8B; TIME FACTORS;

ENA;

EID: 3442895601     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1003495     Document Type: Conference Paper

References (34)

1. Geng, J. G. (2001) Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies. Cell Res. 11, 85-88.
2. Doerschuk, C. M. (2001) Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 8, 71-88.
3. Lopez, A. D., Murray, C. C. (1998) The global burden of disease, 1990-2020. Nat. Med. 4, 1241-1243.
4. de Boer, W. I., Sont, J. K., van Schadewijk, A., Stolk, J., van Krieken, J. H., Hiemstra, P. S. (2000) Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J. Pathol. 190, 619-626.
5. Barnes, P. J. (2003) New concepts in chronic obstructive pulmonary disease. Annu. Rev. Med. 54, 113-129.
6. Barnes, P. J. (2000) Chronic obstructive pulmonary disease. N. Engl. J. Med. 343, 269-280.
7. Barnes, P. J. (2002) New treatments for COPD. Nat. Rev. Drug Discov. 1, 437-446.
8. Keatings, V. M., Collins, P. D., Scott, D. M., Barnes, P. J. (1996) Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 153, 530-534.
9. Traves, S. L., Culpitt, S. V., Russell, R. E. K., Barnes, P. J., Donnelly, L. E. (2002) Elevated levels of the chemokines GRO and MCP-1 in sputum samples from COPD patients. Thorax 57, 586-589.
10. Pesci, A., Balbi, B., Majori, M., Cacciani, G., Bertacco, S., Alciato, P., Donner, C. F. (1998) Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur. Respir. J. 12, 380-386.
11. Cambien, B., Pomeranz, M., Millet, M. A., Rossi, B., Schmid-Alliana, A. (2001) Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood 97, 359-366.
12. Capelli, A., Di-Stefano, A., Gnemmi, I., Balbo, P., Cerutti, C. G., Balbi, B., Lusuardi, M., Donner, C. F. (1999) Increased MCP-1 and MIP-1β in bronchoalveolar lavage fluid of chronic bronchitics. Eur. Respir. J. 14, 160-165.
13. Ashida, N., Arai, H., Yamasaki, M., Kita, T. (2001) Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis. J. Biol. Chem. 276, 16555-16560.
14. Van-Damme, J., Proost, P., Put, W., Arens, S., Lenaerts, J. P., Conings, R., Opdenakker, G., Heremans, H., Billiau, A. (1994) Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J. Immunol. 152, 5495-5502.
15. Callard, R., Gearing, A. (1994) The Cytokine Facts Book. London, UK, Academic.
16. Jinquan, T., Frydenberg, J., Mukaida, N., Bonde, J., Larsen, C. G., Matsushima, K., Thestrup-Pedersen, K. (1995) Recombinant human growth-regulated oncogene-α induces T lymphocyte chemotaxis. A process regulated via IL-8 receptors by IFN-γ, TNF-α, IL-4, IL-10, and IL-13. J. Immunol. 155, 5359-5368.
17. Ludwig, A., Petersen, F., Zahn, S., Gotze, O., Schroder, J. M., Flad, H. D., Brandt, E. (1997) The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 90, 4588-4597.
18. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., Power, C. A. (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145-176.
19. Gerszten, R. E., Garcia-Zepeda, E. A., Lim, Y. C., Yoshida, M., Ding, H. A., Gimbrone Jr., M. A., Luster, A. D., Luscinskas, F. W., Rosenzweig, A. (1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398, 718-723.
20. Horuk, R. (2001) Chemokine receptors. Cytokine Growth Factor Rev. 12, 313-335.
21. Wilkinson, P. C. (1988) Micropore filter methods for leukocyte chemotaxis. Methods. Enzymol. 162, 38-50.
22. Matsushima, K., Larsen, C. G., DuBois, G. C., Oppenheim, J. J. (1989) Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169, 1485-1490.
23. Feniger-Barish, R., Ran, M., Zaslaver, A., Ben Baruch, A. (1999) Differential modes of regulation of CXC chemokine-induced internalization and recycling of human CXCR1 and CXCR2. Cytokine 11, 996-1009.
24. Proudfoot, A. E. (2002) Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2, 106-115.
25. Aaron, S. D., Angel, J. B., Lunau, M., Wright, K., Fex, C., Le Saux, N., Dales, R. E. (2001) Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 349-355.
26. Culpitt, S. V., Maziak, W., Loukidis, S., Nightingale, J. A., Matthews, J. L., Barnes, P. J. (1999) Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160, 1635-1639.
27. Geiser, T., Dewald, B., Ehrengruber, M. U., Clark-Lewis, I., Baggiolini, M. (1993) The interleukin-8-related chemotactic cytokines GRO α, GRO β, and GRO γ activate human neutrophil and basophil leukocytes. J. Biol. Chem. 268, 15419-15424.
28. Walz, A. (1992) Generation and properties of neutrophil-activating peptide 2. Cytokines 4, 77-95.
29. Culpitt, S. V., De Matos, C., Russell, R. E., Donnelly, L. E., Rogers, D. F., Barnes, P. J. (2002) Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 165, 1371-1376.
30. Burnett, D., Chamba, A., Hill, S. L., Stockley, R. A. (1987) Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 2, 1043-1046.
31. Frankenberger, M., Passlick, B., Hofer, T., Siebeck, M., Maier, K. L., Ziegler-Heitbrock, L. H. (2000) Immunologic characterization of normal human pleural macrophages. Am. J. Respir. Cell Mol. Biol. 23, 419-426.
32. Oudijk, E. J., Lammers, J. W., Koenderman, L. (2003) Systemic inflammation in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 46, 5s-13s.
33. Katancik, J. A., Sharma, A., de Nardin, E. (2000) Interleukin 8, neutrophil-activating peptide-2 and GRO-a bind to and elicit cell activation via specific and different amino acid residues of CXCR2. Cytokine 12, 1480-1488.
34. Ben Baruch, A., Grimm, M., Bengali, K., Evans, G. A., Chertov, O., Wang, J. M., Howard, O. M., Mukaida, N., Matsushima, K., Oppenheim, J. J. (1.997) The differential ability of IL-8 and neutrophil-activating peptide-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8 receptor B). J. Immunol. 158, 5927-5933.